Good afternoon and welcome to all of you. We have representatives from the Embassies of Iceland, the Kingdom of Norway and Switzerland. I would like to thank you for coming along today to help us better understand this Free Trade Agreement. We have some questions on the agreement, but I would like to begin by saying that we have a great deal of admiration for your respective small countries. As you are aware, there is a sovereignist movement in Quebec; we want to create a small country of our own with seven million citizens. Small countries such as yours inspire us to fight for our own country.
I know that Switzerland is a leader in the manufacturing of brand-name pharmaceuticals. My first questions is with regard to Switzerland's intentions on this front. Do you plan to manufacture pharmaceuticals in Montreal, an ideal location for such an endeavour, in order to sell more products in North America? Such a decision would also create jobs in Quebec.
I also have a question for Mr. Vatne, the Norwegian representative. As I am sure you are aware, Teco Management acquired Davie Québec, a shipbuilding company, for $28.4 million, a virtual giveaway. The sector has since begun to flourish again. Shipbuilding was heavily subsidized in Norway for a number of years and, even if that is no longer the case, it is something that still causes a lot of concern. I appreciate that there is a 15-year phase-out period for some products and a 10-year phase-out period for products that are more affected by competition; however, some Quebec companies are still concerned.
How do you foresee events unfolding? Are Norwegian shipbuilding companies buying Quebec and Canadian companies as part of a strategy to gain a greater market share?